Apollo Intelligence Incorporates AI-powered Market Analysis Expertise from Trade Innovator SightX to Propel Platform Development

WATERTOWN, Mass.–(BUSINESS WIRE)–Apollo Intelligence (Apollo), world insights innovator for the life sciences, introduced the combination of SightX expertise into its proprietary and industry-leading insights platform as a part of an industry-exclusive growth association focusing on the healthcare and life science market. The brand new providing will profit Apollo’s 450+ life science purchasers, together with 80 of the highest global-100 pharma corporations.

Furthering Apollo’s dedication to growing new, high-quality paths to insights and making certain that its purchasers are at all times benefiting from industry-leading innovation, Apollo is supporting this unique settlement by additionally investing in SightX. Phrases of the funding aren’t being disclosed. By combining SightX’s modern, shopper, technology-enabled analysis instruments with Apollo’s established, trusted, and compliant insights supply safeguards and experience, the SightX addition will speed up and allow extremely superior and distinctive capabilities to the life science market.

As an built-in resolution, SightX will serve to reinforce Apollo’s current information analytics engine, permitting the platform to advance in aggressive analysis areas, similar to conjoint evaluation, warmth mapping, and extra refined video idea testing, amongst different capabilities. The combination may also make cross-tabulation, statistical significance testing, and cluster evaluation extra superior and environment friendly for Apollo and its purchasers. These developments are being delivered to market as a part of each corporations’ dedication to prioritizing a considerate and methodical concentrate on the general person expertise.

“This initiative will allow us to ship extra superior, built-in logic, information analytics, and visualizations to expedite speed-to-insight for our purchasers,” mentioned Daniel S. Fitzgerald, CEO of Apollo. “The combination will deliver rapid worth to purchasers and inner service groups whereas increasing our capability to assemble information and understand the promise of our bold expertise roadmap sooner. The SightX integration and funding replicate our dedication to steady enchancment and ongoing innovation for our purchasers, providing them a uniquely aggressive resolution that empowers them to remain forward of the market.”

SightX’s underlying information analytics capabilities mixed with logic elements inside the Apollo platform will proceed to speed up time-to-insight with capabilities that had been beforehand out of attain for all times science insights professionals. The embedded resolution will elegantly help monitoring and highly-advanced survey logic calls for, increasing Apollo’s capability to serve extra complicated analysis wants inside a mobile-friendly analysis format.

About Apollo Intelligence, LLC

Apollo Intelligence’s mission is to speed up well being innovation to enhance life. In 2019, Apollo launched with the acquisition of InCrowd, the pioneer of real-time automated insights for the life sciences {industry}. To enrich InCrowd and strengthen its world attain, in 2020 Apollo acquired SurveyHealthcareGlobus, the worldwide market chief of first-party healthcare information assortment and customized survey options. Apollo supplies entry to 2M healthcare stakeholders worldwide—together with physicians, sufferers, caregivers, and allied healthcare professionals. Apollo’s 200 workers help prime world pharmaceutical manufacturers, market analysis companies, and consultancies throughout 14 totally different nations within the Americas, Europe, and Asia. For extra details about Apollo, please go to our web site at www.apollointelligence.internet.

Related posts

What Ever Occurred to IBM’s Watson?


Genpact and Not Unimaginable Be a part of Forces, Leveraging Expertise to Struggle Meals Insecurity at Scale | Information


Jericho Expands Vitality Portfolio with Settlement for the Acquisition of Hydrogen Expertise TSX Enterprise Change:JCO


Leave a Comment